133 related articles for article (PubMed ID: 2318481)
21. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
22. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases.
Bostwick DG; Tazelaar HD; Ballon SC; Hendrickson MR; Kempson RL
Cancer; 1986 Nov; 58(9):2052-65. PubMed ID: 3756820
[TBL] [Abstract][Full Text] [Related]
23. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
24. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
25. Epithelial ovarian tumors of borderline malignancy.
Chao TM; Yen MS; Chao KC; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
[TBL] [Abstract][Full Text] [Related]
26. Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution.
Okoye E; Euscher ED; Malpica A
Am J Surg Pathol; 2016 May; 40(5):627-35. PubMed ID: 26900814
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
[TBL] [Abstract][Full Text] [Related]
28. Microinvasion in low malignant potential tumors of the ovary.
Nayar R; Siriaunkgul S; Robbins KM; McGowan L; Ginzan S; Silverberg SG
Hum Pathol; 1996 Jun; 27(6):521-7. PubMed ID: 8666359
[TBL] [Abstract][Full Text] [Related]
29. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
Djordjevic B; Malpica A
Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
[TBL] [Abstract][Full Text] [Related]
30. Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential.
Silva EG; Tornos C; Zhuang Z; Merino MJ; Gershenson DM
Int J Gynecol Pathol; 1998 Jan; 17(1):1-6. PubMed ID: 9475184
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases.
Lim-Tan SK; Cajigas HE; Scully RE
Obstet Gynecol; 1988 Nov; 72(5):775-81. PubMed ID: 3173929
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
[TBL] [Abstract][Full Text] [Related]
33. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report.
Attar E; Berkman S; Topuz S; Baysal B; Akhan S; Chambers JT
Hum Reprod; 2004 Jun; 19(6):1472-5. PubMed ID: 15105388
[TBL] [Abstract][Full Text] [Related]
34. Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
BJOG; 2009 May; 116(6):860-2. PubMed ID: 19432576
[TBL] [Abstract][Full Text] [Related]
35. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
[TBL] [Abstract][Full Text] [Related]
36. Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases.
Bell DA; Scully RE
Am J Surg Pathol; 1985 Mar; 9(3):205-14. PubMed ID: 3993832
[TBL] [Abstract][Full Text] [Related]
37. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
[TBL] [Abstract][Full Text] [Related]
38. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
[TBL] [Abstract][Full Text] [Related]
39. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
40. Serous and mucinous borderline (low malignant potential) tumors of the ovary.
Acs G
Am J Clin Pathol; 2005 Jun; 123 Suppl():S13-57. PubMed ID: 16100867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
